Literature DB >> 17183549

Parkinson's disease and working capacity.

Kirsti K Martikainen1, Tiina H Luukkaala, Reijo J Marttila.   

Abstract

The purpose of the present study was to establish how Parkinson's disease (PD) affects working capacity. Altogether, 937 (70%) of 1,343 working-aged members of the Finnish Parkinson Association participated in a questionnaire study. The ages of the subjects were between 29 and 65 years, median 59.0 years; 508 (54%) were men. The median (quartile range) duration of PD symptoms was 7.3 (4.3-11.3) years, and the median self-estimated severity of the disease on the Hoehn & Yahr scale was 2. Only 150 of 937 subjects (16%) were still working: 112 (12%) full-time and 38 (4%) part-time. Among those 343 (37%) who had retired purely because of PD at a median age of 53.4 years, the median working time was 1.7 years after established diagnosis. In part-time work, PD patients had been able to continue for a median of 4.3 years. PD often leads to early retirement; compared with the general Finnish population of similar age, PD patients had retired on the average 6 years earlier. Young age, mild symptoms, and short duration of the disease as well as adjustments enabling easier employment were associated with the possibility to continue longer in the work force. Copyright 2006 Movement Disorder Society.

Entities:  

Mesh:

Year:  2006        PMID: 17183549     DOI: 10.1002/mds.21171

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  16 in total

Review 1.  Integrating Patient Concerns into Parkinson's Disease Management.

Authors:  Shen-Yang Lim; Ai Huey Tan; Susan H Fox; Andrew H Evans; Soon Chai Low
Journal:  Curr Neurol Neurosci Rep       Date:  2017-01       Impact factor: 5.081

2.  Association between chronic morbidity and early retirement in Italy.

Authors:  Tiziana Li Ranzi; Angelo d'Errico; Giuseppe Costa
Journal:  Int Arch Occup Environ Health       Date:  2012-04-03       Impact factor: 3.015

Review 3.  Early versus delayed initiation of pharmacotherapy in Parkinson's disease.

Authors:  Matthias Löhle; Carl-Johan Ramberg; Heinz Reichmann; Anthony H V Schapira
Journal:  Drugs       Date:  2014-04       Impact factor: 9.546

4.  How parkinsonism influences life: the patients' point of view.

Authors:  E Martignoni; Antonietta Citterio; R Zangaglia; L Godi; C Pacchetti; C Fundarò; E Corengia; G Bono; G Nappi
Journal:  Neurol Sci       Date:  2010-11-06       Impact factor: 3.307

5.  Association of rheumatic diseases with early exit from paid employment in Portugal.

Authors:  Pedro A Laires; Miguel Gouveia
Journal:  Rheumatol Int       Date:  2014-01-31       Impact factor: 2.631

6.  Loss of ability to work and ability to live independently in Parkinson's disease.

Authors:  Barbara Jasinska-Myga; Michael G Heckman; Christian Wider; John D Putzke; Zbigniew K Wszolek; Ryan J Uitti
Journal:  Parkinsonism Relat Disord       Date:  2011-10-04       Impact factor: 4.891

7.  The health-related, social, and economic consequences of parkinsonism: a controlled national study.

Authors:  Poul Jennum; Marielle Zoetmulder; Lise Korbo; Jakob Kjellberg
Journal:  J Neurol       Date:  2011-03-11       Impact factor: 4.849

8.  Parkinson's disease: how is employment affected?

Authors:  R Murphy; N Tubridy; H Kevelighan; S O'Riordan
Journal:  Ir J Med Sci       Date:  2013-01-17       Impact factor: 1.568

9.  Facilitating empowerment in employees with chronic disease: qualitative analysis of the process of change.

Authors:  Inge Varekamp; Annelies Heutink; Selma Landman; Cees E M Koning; Gabe de Vries; Frank J H van Dijk
Journal:  J Occup Rehabil       Date:  2009-07-07

10.  Empowering employees with chronic diseases; development of an intervention aimed at job retention and design of a randomised controlled trial.

Authors:  Inge Varekamp; Gabe de Vries; Annelies Heutink; Frank J H van Dijk
Journal:  BMC Health Serv Res       Date:  2008-11-04       Impact factor: 2.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.